Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of this study is to determine the effect of pregabalin versus dexmedetomidine on the treatment and lasting duration of delirium in fast tracking elderly patients after Coronary Artery Bypass Grafting.
Delirium is an acute brain disorder that involves changes in consciousness, attention, cognition, and perception.The incidence of postoperative delirium (POD) is high among patients undergoing cardiac surgery, ranging from 20 to 50%, and the risk is even higher in the elderly.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pregabalin group | Active Comparator | Patients will receive pregabalin capsules (75 mg) every 12 h for 24 hours by nasogastric tube. |
|
| Dexmedetomidine group | Active Comparator | Patients will receive a bolus dose of 0.4 μg/kg dexmedetomidine (over a period of 10 to 20 min) followed by an infusion of 0.2 to 0.7 μg/h. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pregabalin | Drug | Patients will receive pregabalin capsules (75 mg) every 12 h for 24 hours by nasogastric tube. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percent of delirium treatment | Assessment of delirium will be performed preoperatively and postoperatively at 12-h intervals or as needed according to the patient's condition using the confusion assessment method (CAM) | 24 hour postoperatively |
| Measure | Description | Time Frame |
|---|---|---|
| Level of sedation | Sedation level will be assessed by using the Ramsey sedation scale. | 24 hour postoperatively |
| Incidence of weaning from mechanical ventilation | percent of patients who weaned from mechanical ventilation |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Islam Morsy, MD | Contact | 00201093387374 | eslam.morsy@med.tanta.edu.eg |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Islam Morsy | Recruiting | Tanta | El-Gharbia Governorate | Egypt |
The data will available upon reasonable request from the principal investigator
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000069583 | Pregabalin |
| D020927 | Dexmedetomidine |
| ID | Term |
|---|---|
| D005680 | gamma-Aminobutyric Acid |
| D000613 | Aminobutyrates |
| D002087 | Butyrates |
| D000144 | Acids, Acyclic |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Dexmedetomidine | Drug | Patients will receive a bolus dose of 0.4 μg/kg dexmedetomidine (over a period of 10 to 20 min) |
|
| 1 week postoperatively |
| Length of hospital stay | 1 month postoperatively |
| D002264 |
| Carboxylic Acids |
| D009930 | Organic Chemicals |
| D000596 | Amino Acids |
| D000602 | Amino Acids, Peptides, and Proteins |
| D007093 | Imidazoles |
| D001393 | Azoles |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |